American Custom Technologies, LLC – Trademark Portfolio
Entity Type: 16
American Custom Technologies, LLC holds 2 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 3 (Cosmetics & Cleaning) — 1 filings in this category. The portfolio also extends into Class 5 (Pharmaceuticals) across 2 Nice Classification classes. Currently, 2 trademarks are registered. Notable registered marks include RELEEF DIRECT SOLUTIONS. The owner is based in Oceanside, CA.
2625 Temple Heights Drive, Suite C
Oceanside, CA 92056
Showing of trademarks Trademarks
Trademark Classifications
American Custom Technologies, LLC's trademark portfolio spans 2 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.
Bleaching preparations and other substances for laundry use; cleaning, polishing, scouring
Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes
Frequently Asked Questions
How many trademarks does American Custom Technologies, LLC have?
American Custom Technologies, LLC has 2 U.S. trademarks filed with the USPTO. Of these, 2 registered.
What trademark classes does American Custom Technologies, LLC file in?
American Custom Technologies, LLC files trademarks across 2 Nice Classification classes. The most active classes are Class 3 (Cosmetics & Cleaning), Class 5 (Pharmaceuticals). Class 3 covers bleaching preparations and other substances for laundry use; cleaning, polishing, scouring.
What are American Custom Technologies, LLC's most well-known trademarks?
American Custom Technologies, LLC's registered trademark portfolio includes well-known marks such as RELEEF DIRECT SOLUTIONS. These are among 2 currently registered trademarks in the portfolio.
What is American Custom Technologies, LLC's trademark registration success rate?
American Custom Technologies, LLC has a 100% trademark registration rate, with 2 out of 2 resolved applications resulting in successful registration. Currently, 0 applications are pending review.